Wayne P. Rothbaum

That's a leased drug.

Bobby Dugan and Wayne Rothbaum.

Dugan owns Summit.

Rothbaum is one of the biggest investors in Iovance.

Bolt-on..." Who hears that five times in a minutes meeting? Nobody.

They were telling us we're being bought out, and that's why I said they cost me a million bucks, because I could have sold and had it right there, and I waited for the buyout that never came, and then I rode it all the way down and bought it all the way down and all the way back up to get, you know, my healthy bunch of shares I have now.

So to answer your question, is it designed to be bought out? Everything Wayne Rothbaum does is designed to be bought out.

But keep in mind, they didn't realize they had a platform when he got involved.

Because if Merck acquires the staff and in the book for blood and money, they actually talk about this exact scenario.

And Wayne Rothbaum, who was the...

He actually is one of the board members of Iovance Biotherapeutics.

But he was running the other company in that book, the rival of Bob Dugan.

And the acquiring company was going to take it over and get rid of those employees.

And these were key employees before they were able to vest.

And Wayne Rothbaum and the management team said, this is not fair.

So they made like a separate fund.